Veyrier FJ - Search Results

1

atpE gene as a new useful specific molecular target to quantify Mycobacterium in environmental samples.

Radomski N, Roguet A, Lucas FS, Veyrier FJ, Cambau E, Accrombessi H, Moilleron R, Behr MA, Moulin L. Radomski N, et al. Among authors: veyrier fj. BMC Microbiol. 2013 Dec 3;13:277. doi: 10.1186/1471-2180-13-277. BMC Microbiol. 2013. PMID: 24299240 Free PMC article.

2

The rise and fall of the Mycobacterium tuberculosis genome.

Veyrier FJ, Dufort A, Behr MA. Veyrier FJ, et al. Trends Microbiol. 2011 Apr;19(4):156-61. doi: 10.1016/j.tim.2010.12.008. Epub 2011 Feb 1. Trends Microbiol. 2011. PMID: 21277778

3

Phylogenetic detection of horizontal gene transfer during the step-wise genesis of Mycobacterium tuberculosis.

Veyrier F, Pletzer D, Turenne C, Behr MA. Veyrier F, et al. BMC Evol Biol. 2009 Aug 10;9:196. doi: 10.1186/1471-2148-9-196. BMC Evol Biol. 2009. PMID: 19664275 Free PMC article.

4

Emergence of persistent tubercle bacilli.

Veyrier FJ, Behr MA. Veyrier FJ, et al. Nat Microbiol. 2021 Aug;6(8):977-978. doi: 10.1038/s41564-021-00945-5. Nat Microbiol. 2021. PMID: 34326521 No abstract available.

5

Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii.

Wang J, McIntosh F, Radomski N, Dewar K, Simeone R, Enninga J, Brosch R, Rocha EP, Veyrier FJ, Behr MA. Wang J, et al. Among authors: veyrier fj. Genome Biol Evol. 2015 Feb 25;7(3):856-70. doi: 10.1093/gbe/evv035. Genome Biol Evol. 2015. PMID: 25716827 Free PMC article.

6

Evolution of the mycobacterial SigK regulon.

Veyrier F, Saïd-Salim B, Behr MA. Veyrier F, et al. J Bacteriol. 2008 Mar;190(6):1891-9. doi: 10.1128/JB.01452-07. Epub 2008 Jan 18. J Bacteriol. 2008. PMID: 18203833 Free PMC article.

7

N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis.

Hansen JM, Golchin SA, Veyrier FJ, Domenech P, Boneca IG, Azad AK, Rajaram MV, Schlesinger LS, Divangahi M, Reed MB, Behr MA. Hansen JM, et al. Among authors: veyrier fj. J Infect Dis. 2014 Apr 1;209(7):1045-54. doi: 10.1093/infdis/jit622. Epub 2013 Nov 21. J Infect Dis. 2014. PMID: 24265438

8

RskA Is a Dual Function Activator-Inhibitor That Controls SigK Activity Across Distinct Bacterial Genera.

Veyrier FJ, Nieves C, Lefrancois LH, Trigui H, Vincent AT, Behr MA. Veyrier FJ, et al. Front Microbiol. 2020 Sep 9;11:558166. doi: 10.3389/fmicb.2020.558166. eCollection 2020. Front Microbiol. 2020. PMID: 33013790 Free PMC article.

9

Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Coulombe F, Divangahi M, Veyrier F, de Léséleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA. Coulombe F, et al. J Exp Med. 2009 Aug 3;206(8):1709-16. doi: 10.1084/jem.20081779. Epub 2009 Jul 6. J Exp Med. 2009. PMID: 19581406 Free PMC article.

10

NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.

Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, Veyrier F, Kobayashi KS, Flavell RA, Gros P, Behr MA. Divangahi M, et al. J Immunol. 2008 Nov 15;181(10):7157-65. doi: 10.4049/jimmunol.181.10.7157. J Immunol. 2008. PMID: 18981137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page